CD8A and neoplasm: Understanding the efficiency of HBV epitope presentation in HBV-infected primary hepatocytes or tumor cells carrying HBV DNA integration will allow the generation of engineered CD8+ T cells with T cell receptors specific for epitopes mainly produced by HCC cells and not by HBV-infected hepatocytes.